These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11862745)

  • 1. One copy of mutation may help resistance: study.
    AIDS Alert; 2002 Feb; 17(2):23-4, 14. PubMed ID: 11862745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.
    Gonzalez S; Tirado G; Revuelta G; Yamamura Y; Lu Y; Nerurkar VR; Yanagihara R
    Bol Asoc Med P R; 1998; 90(1-3):12-5. PubMed ID: 9734151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inheritance pattern of mutant human immunodeficiency virus type 1 coreceptor gene CCR5 in an Indian family.
    Husain S; Goila R; Shahi S; Banerja AC
    J Hum Virol; 1998; 1(3):187-92. PubMed ID: 10195241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible influence of the mutant CCR5 Allele on vertical transmission of HIV-1.
    Mandl CW; Aberle SW; Henkel JH; Puchhammer-Stöckl E; Heinz FX
    J Med Virol; 1998 May; 55(1):51-5. PubMed ID: 9580886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical model offers clues to Africa epidemic.
    AIDS Alert; 2001 Nov; 16(11):149-50, 138. PubMed ID: 11692670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of the CCR5-delta 32 chemokine receptor gene mutation in the Lebanese population.
    Karam W; Jurjus R; Khoury N; Khansa H; Assad C; Zalloua P; Jurjus A
    East Mediterr Health J; 2004; 10(4-5):671-5. PubMed ID: 16335661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.
    Ristić S; Starcević Cizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M
    Croat Med J; 2005 Aug; 46(4):693-4. PubMed ID: 16100775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the HIV-1 protective Delta ccr5 allele in most ethnic populations of India.
    Majumder PP; Dey B
    Eur J Hum Genet; 2001 Oct; 9(10):794-6. PubMed ID: 11781692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].
    Motta P; Cibulsky L; Iliovich E; Habegger de Sorrentino A
    Medicina (B Aires); 2000; 60(4):431-4. PubMed ID: 11188946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Population features of gene mutation frequency of the CKR-5 receptor, determining sensitivity to the AIDS virus].
    Aseev MV; Shawi A; Dean M; Baranov VS
    Genetika; 1997 Dec; 33(12):1724-6. PubMed ID: 9493032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.